Profile
Benjamin Perry is the founder of MPC Therapeutics SA, holding the title of Director since 2018.
Dr. Perry is a Venture Partner at Medicxi Ventures (Jersey) Ltd. since 2022.
Education includes a doctorate from Imperial College London, conferred in 2002, and a graduate degree from Swansea University, conferred in 1999.
Benjamin Perry active positions
| Companies | Position | Start |
|---|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Private Equity Investor | 2022-10-31 |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology Develops small molecules which modulate mitochondrial functions | Founder | 2017-12-31 |
Training of Benjamin Perry
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swansea University
Swansea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Finance |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology Develops small molecules which modulate mitochondrial functions | Health Technology |
- Stock Market
- Insiders
- Benjamin Perry
















